BDBM437036 6-(5-Chloro-4-methyl-2-thienyl)-1-[(5-chloro-3-pyridyl)methyl]-3-methyl- imidazo[4,5-b]pyridin-2-one::US10617676, Example 372::US11207298, Example 372

SMILES Cc1cc(sc1Cl)-c1cnc2n(C)c(=O)n(Cc3cncc(Cl)c3)c2c1

InChI Key InChIKey=HKHUYNLFJGXKRR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 437036   

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437036(US10617676, Example 372 | 6-(5-Chloro-4-methyl-2-t...)
Affinity DataIC50: 6.64E+3nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437036(US10617676, Example 372 | 6-(5-Chloro-4-methyl-2-t...)
Affinity DataIC50: 6.64E+3nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
US Patent